Changes in absolute coronary blood flow and myocardial resistance after percutaneous coronary intervention

Federico Marin1,2, Samer Fawaz2,3, Rafail A Kotronias4

  • 1Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, United Kingdom.

Insights

Percutaneous coronary intervention (PCI) reduces epicardial resistance, increasing hyperaemic flow. Resting coronary flow remains unchanged due to compensatory microvascular resistance increases, demonstrating human coronary flow autoregulation.

Area of Science:

  • Cardiovascular physiology
  • Interventional cardiology
  • Medical device technology

Background:

  • Percutaneous coronary intervention (PCI) aims to improve myocardial ischemia by enhancing coronary blood flow.
  • The precise changes in coronary flow and resistance following PCI are not fully elucidated.

Purpose of the Study:

  • To investigate the immediate effects of PCI on absolute coronary flow (Q) and both epicardial (Repi) and microvascular (Rμ) resistance.
  • To assess the relationship between fractional flow reserve (FFR) and post-PCI coronary hemodynamics.

Main Methods:

  • A prospective, two-center study involving 52 patients undergoing PCI.
  • Physiological assessments utilized continuous thermodilution with a pressure-temperature sensor wire and a microcatheter for infusion.

Main Results:

  • Resting coronary flow (Q) showed no significant change post-PCI (p=0.21).
  • Epicardial resistance (Repi) decreased significantly at rest and during hyperemia (p<0.001).
  • Microvascular resistance (Rμ) increased at rest (p=0.002) but remained stable during hyperemia (p=0.87).
  • Hyperemic flow significantly increased post-PCI (p<0.001).
  • Microvascular resistance reserve (MRR) remained unchanged (p=0.301).
  • FFR strongly correlated with Repi and predicted hyperemic flow improvement.

Conclusions:

  • PCI effectively reduces epicardial resistance, leading to increased hyperemic coronary flow, predictable by FFR.
  • Unchanged resting flow is attributed to compensatory microvascular resistance increases, indicating human coronary autoregulation.
  • Unaffected MRR confirms its role as a specific indicator of microvascular function.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
347
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
349
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
342
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.7K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.3K
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
570